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Abstract
Chronic rejection remains a potential long-term consequence of hand composite tissue allotransplantation (CTA).
Scleroderma has already been proposed as a model for chronic facial allograft rejection based on potential
parallels of observed progression of disease and pathophysiology course. This study proposes a similar model for how
chronic rejection may manifest itself in the context of hand CTA through the functional and psychological assessment
of patients with scleroderma, should it occur.
Methods: 100 consecutive patients with a clinical diagnosis of scleroderma were recruited into the study. Subjective
assessment of static hand disfigurement was carried out through the use of standardised digital photographs. Hand
function was assessed through the measurement of active range of motion (AROM) and using the activities of daily
living (ADL) and Disabilities of the Arm, Shoulder & Hand (DASH) questionnaire. Psychological and quality of life
evaluation comprised the Hospital Anxiety Depression Scale (HADS) and the SF36 health survey.
Results: Examination of standardised digital photographs of subjects revealed a variety of hand changes
characteristic of scleroderma, ranging from mild to moderate through to severe. Objective assessment of hand
disfigurement did not correlate with duration of disease, nor psychological distress. However, individuals with
worsening disfigurement demonstrated poorer AROM. Longitudinally no deterioration in terms of function was
seen over time in terms of the DASH and ADL results. Nevertheless deterioration of function did have a significant
impact on quality of life. Overall HADS showed 22% of individuals as suffering from clinical levels of anxiety and
10% from clinical depression.
Conclusion: Chronic rejection has not yet occurred in any of the hand transplants performed to date.
Scleroderma results in a spectrum of chronic functional and psychological disability that provides a model for the
potential outcome of chronic hand allograft rejection. Findings from this study provide insight into the impact of
this progressive disease for patients and contribute to the information and consent process for patients
c o n s i d e r i n gh a n dc o m p o s i t etissue transplantation.
Introduction
Composite tissue allotransplantation (CTA) is a significant
development in reconstructive surgery. The world’sf i r s t
hand transplant was performed in 1998 and was heralded as
a major advance in reconstructive surgery (Dubernard et al.
1999). To date (August 2013), more than 85 hand trans-
plants have been performed worldwide (IRHCTT, 2002).
Secondary to infection, the most significant complica-
tions encountered so far in hand CTA have been those of
acute rejection (Unadkat et al. 2013). However, over the last
30 years significant advances in immunosuppression have
been made with the development of potent immunosup-
pressive agents such as calcineurin inhibitors (cyclosporine,
tacrolimus), anti-proliferatives such as mycophenolate mo-
fetil, and corticosteroids. As a result of early recognition
and treatment, acute rejection has become consistently re-
versible. Despite successful results, issues surrounding the
risk-benefit ratio of long-term immunosuppression, and the
potential for chronic rejection remain.
Currently, insufficient studies and analysis are available
to define specific histopathological changes in chronic
CTA rejection. Histological examination of one of the
three hand transplants carried out in the United States has
revealed features of ischaemic damage that may be the re-
sult of progressive arteriopathy of chronic rejection. In
* Correspondence: kavamin@yahoo.co.uk
Plastic and Reconstructive Surgery, Royal Free Hospital, Pond Street, NW3,
London, UK
a SpringerOpen Journal
© 2013 Amin et al.; licensee Springer. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
in any medium, provided the original work is properly cited.
Amin et al. SpringerPlus 2013, 2:577
http://www.springerplus.com/content/2/1/577addition the onset of vascular narrowing, loss of skin ad-
nexa, skin and muscle atrophy with fibrosis of deeper tis-
sues has also been suggested (Pidwell & Burns 2007;
Cendales et al. 2008). Clinicopathological features of graft
rejection in the first human allograft at month 29 did not
include deeper biopsies to assess the degree of deeper tis-
sue rejection. This particular case of acute rejection was a
result of non-compliance with immunosuppressive ther-
apy. The authors report they did not observe scleroderma
like features but suggest this most probably occurs with
time (Kanitakis et al. 2003).
An erythematous maculopapular lesion present on skin
allograft represents the macroscopic appearance of acute
rejection. The main histological feature is that of monocu-
clear cell infiltrate, appearing first in the perivascular space
of the dermis, progressing to the interface between dermis
and epidermis. Necrosis then occurs resulting in dermal-
epidermal separation. It is felt that the strong immune re-
sponse can be attributed to increased antigenicity of skin.
The high number of Antigen Presenting Cells and kera-
tinocytes leads to expression of MHC molecules result-
ing in the secretion of chemokines, further attracting
lymphocytes. This acute rejection response has been
likened to that of atopic dermatitis and psoriasis, in
that they mirror skin allograft rejection with regard to
histopathological findings and composition of infiltrate
in skin (Schneeberger et al. 2009).
Scleroderma has been proposed as a clinical correlate
for chronic rejection in facial allograft transplantation,
though to date this has not yet been proven as there
have been no cases of chronic facial graft rejection (Siva-
kumar et al. 2010). Scleroderma is characterized by ex-
cessive extracellular matrix in the skin with atrophy of
the epidermis. Histological analysis reveals perivascular
invasion with interstitial lymphocytic infiltration, atro-
phy of adnexal structures, increased number of fibro-
blasts with thickening and intra luminal narrowing of
the vasculature (Cendales et al. 2008).
Around 90% of patients report some deterioration in
hand functionality (Casale et al. 1997). Patients present
with swelling of the hands, skin thickening and arthralgias
with a rapid symmetrical skin fibrosis affecting the distal
extremities. Such impairment interferes with activities of
daily living, more specifically with the performance of
everyday tasks such as grasp, pinch and object manipula-
tion (Sandqvist & Eklund 2000). In addition, the hands,
like the face are visible to other individuals and therefore
are potentially stigmatising (Heinberg et al. 2007).
This study has been designed to objectively and sub-
jectively measure the functional and psychological im-
pact of scleroderma on the hands of a cohort of patients
with scleroderma, and attempt to understand the way in
which chronic rejection may manifest in the context of
rejection in chronic hand transplantation.
Materials and methods
100 consecutive patients with a confirmed clinical diagnosis
of scleroderma for consistency were recruited into the study.
The diagnosis was based on the American College of
Rheumatology classification criteria for scleroderma.
Patients with localised scleroderma such as morphea or lin-
ear scleroderma were excluded from the study. Clinical diag-
nosis of scleroderma subtypes was confirmed via LeRoy’s
criteria (1981). Ethical approval was gained from the Ethics
Committee and full informed consent was obtained from
each patient prior to recruitment into the study. The cos-
metic, functional and psychological impact of the disease
within hand scleroderma was assessed in the following ways.
Objective measures
Observer rated disfigurement
Standardised images of the palmar, dorsal and lateral views
of both hands were captured using a digital Cannon Ixus
400 camera. Severity of disfigurement was ranked into 3
categories based on a 9-point disfigurement scale, ranging
from 1–3 (mild disease), 4–6 (moderate disease) 7–9
(severe disease) (Figure 1a) (Katz et al. 2000). Three inde-
pendent assessors rated the images in terms of whether
they felt the appearance of patient hands represented mild,
moderate or severe disease based on supplying a numer-
ical number. Images with less than 100% agreement on
category agreement were discarded.
Percentage active range of motion (AROM)
AROM measurements were taken at the wrist, meta-
carpophalangeal (MCP) and interphalangeal joints. The
average percentage AROM of patients’ dominant hand
joints was calculated by the same trained observer in
line with the method employed for hand assessment by
Lanzetta et al. in their study post hand transplantation
(Provins 1997; Dubernard et al. 2003).
Subjective measures
Activities of daily living (ADL) questionnaire
The activities of daily living (ADL) questionnaire was de-
rived from studies of hand function as reported by the
International registry on hand and composite tissue trans-
plantation (Georges et al. 2004). Set up in May 2002, all
groups performing hand transplants around the world
have supplied information to the International Registry on
Hand and Composite Tissue Transplantation (IRHCTT).
The assessment allowed subjects to rank the ability to per-
form ADLs as, 0 (Impossible), 1 (Difficult) and 2 (Easy).
Disabilities of the Arm, shoulder & hand (DASH)
questionnaire
The DASH questionnaire was developed by the American
Academy of Orthopaedic Surgeons as a region-specific in-
strument for measuring upper-extremity disability and
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dated and has been shown to be reliable in patients with
various upper-extremity disorders. 88 patients completed
the DASH questionnaire.
Psychological and quality of life assessment
The following validated questionnaires were used:
The hospital anxiety and depression scale (HADS)
This is a psychometrically robust scale standardised on a
hospital population. Each subscale (anxiety and depres-
sion) is scored from 0–21 with cut-offs of 8–10 (mild),
11–15 (moderate) and 16+ (severe) used as indicative of
clinical caseness (Snaith & Zigmond 1986).
The short form-36 (SF-36)
TheSF-36comprisesbothaphysicalandmentalhealthcom-
ponent and is widely used in clinical research. Previously
used in scleroderma, scores have been shown to correlate
well with severity of disease, and it has been reported to
be accurate in evaluating QOL in this condition (Lewis &
Wessely1990;Georges et al.2004;Danieliet al.2005).
Statistical analyses
Graph Pad Prism (Graph Pad Software, CA, USA) was used
in the analysis of the data. A Bland-Altman analysis was
carried out using Prism software, which showed no signifi-
cant inter-observer variability with relation to the assess-
ment of disfigurement. To compare two sets of variables, a
Pearson correlation was used for normally distributed data,
and a Spearman correlation for non-Gaussian data.
Mild Moderate Severe
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Figure 1 Hand disfigurement grading and analysis. a. Disfigurement was graded using a validated 9-point disfigurement scale. b (a,b,c).
Hand disfigurement analysis – standardized digital photographs of hands of scleroderma patients.
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The demography of the cohort of 100 consecutive pa-
tients was typical of scleroderma with mean age of 54.7
years (range 17 to 100 years) and a female predominance
(87.2%). Duration of disease (time since diagnosis)
ranged from 1.5 years to 45 years, which was reflected in
the broad range of disease patterns seen with a median
of 8.5 years.
Observer rated disfigurement
Digital photographs of 78 patients’ hands showed early
skin changes including thickening, telangiectasia, a shiny
taut appearance and soft tissue oedema (Figure 1b (a)).
Areas of ulceration and pitted scars secondary to digital
ischaemia together with muscular atrophy were seen in
worsening cases (Figure 1b (b)). More advanced disease
was compounded by joint contractures as a result of
peri-articular fibrosis (Figure 1b (c)). Average disfigure-
ment scores ranged from 1 to 8.67 with a median of
1.84. 51 (66%) patients were classified as mild, 17 (22%)
patients as moderate and 9 (12%) patients as severe.
Scores were not significantly associated with duration of
disease (p>0.05), nor with any of the QOL results.
Percentage active range of motion (AROM)
Percentage active range of motion (AROM) was mea-
sured in the dominant hands of 98 patients. AROM
scores ranged from 31% to 99% with a median of 75.5%
(Figure 2a). Disease duration had no impact upon the
active range of motion in our cohort (p >0.05). Wor-
sening AROM correlated significantly with worsening
disfigurement (r=−0.359 p<0.01) (Figure 2b). No sig-
nificant correlation was seen between AROM and psy-
chological distress. AROM did not correlate with our
other functional assessments.
Activities of daily living (ADL) questionnaire
100 patients completed the Activities of daily living
(ADL) questionnaire. From a maximum score of 20, our
scores ranged from 3 to 20, with a median score of 4.
Ability to perform ADL was seen to not significantly de-
teriorate over time (r=−0.204, p<0.01). A significant
positive correlation between ability to perform ADLs,
and the physical component of the SF-36 score was
found (r =0.305 p <0.01). The QOL physical component
of the SF36 declined with worsening ADL scores.
Disabilities of the Arm, shoulder & hand (DASH)
questionnaire
DASH scores from the study cohort ranged from a mini-
mum of 1.79 to a maximum score of 89.17, with a me-
dian of 41.96. DASH scores significantly deteriorated
over time (p>0.05).
Upper limb disability reduced the ability to perform
ADL (r=−0.537 p<0.01) but did not correlate with
hand disfigurement. Reduced QOL scores for both the
physical (r=−0.535 p <0.05) and mental component
(r=−0.397 p<0.05) were found with increasing upper
limb disability.
Psychological assessment
67% of patients completed the Hospital Anxiety and
Depression scale (HADS) questionnaire (26). 40 (60%)
patients were categorized as having non-case levels
of anxiety, 12 (18%) as borderline anxiety and 15 (22%)
of individuals categorized as experiencing clinical levels
of anxiety. 68% of subjects classified as having non-case
levels of depression, 15 (22%) as having borderline
depression and 7 (10%) as having clinical depression.
69% of individuals completed the SF-36 health survey.
Scores of the mental component ranged from 43.66 to
62.4, with a median of 48.9.
Discussion
Chronic rejection remains a potential future conse-
quence in hand CTA. Rejection amongst individuals
having received a hand CTA are graded based on mor-
phological features. There is agreement that progressive
perivascular lymphocytic infiltrate occurs with increasing
rejection with inflammation of the dermal stroma, epi-
dermis and adnexa with epidermal apoptosis in severe
cases. Scleroderma has been proposed as a clinical cor-
relate for chronic rejection in facial allotransplantation
based on potential parallels of pathophysiology and dis-
ease course (Sivakumar et al. 2010). Chronic changes in
a nonhuman primate model of hand transplantation was
characterized by arteritis, vasculopathy and intimal hy-
perplasia progressing to vessel occlusion. The grafts ap-
peared pale and oedematous, these findings mirroring to
a degree findings in progressive scleroderma (Mundinger
et al. 2013). Previous studies have shown that skin de-
formity is a core stressor within the scleroderma po-
pulation (Benrud-Larson et al. 2002).
Assessment of standardised photographs revealed a
broad range of disease, from mild through to severe.
The cohort was representative of the spectrum of
changes that would be seen in a chronic rejection
process. Presentations in 4 chronic hand rejection trans-
plant recipients have involved a desquamative red pa-
pular rash, lichenification of the palm and dystrophic
changes to the nail with eventual loss of the nail, similar
charateristics seen in our scleroderma population
(Ravindra et al. 2012).
In our study, with time appearance did not worsen.
Furthermore, despite many subjects reporting skin
changes as a major concern, no relationship could be
seen between psychological wellbeing and severity of
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a defining factor in patients’ perception of the severity of
hand disease. However, this may in some way be related
to the cross-sectional nature of our study. A longitudinal
analysis of a larger cohort of patients would be useful
(van Lankveld et al. 2007).
Individuals with scleroderma commonly suffer from
rheumatic problems. Articular manifestations may be
the presenting feature in the majority of patients, and
clinically manifest as arthralgia, flexion contractures and
in fewer cases as arthritis which have an impact on func-
tionality (Pope 2003). In line with our cosmesis findings,
disease duration appeared to have no effect on hand
joint mobility. However, with increasing disfigurement,
we saw worsening joint motion. Additionally, we identi-
fied that with longer disease duration, the more limited
individuals were in their ADL. However, despite deteri-
oration in mobility, patients were able to adapt remark-
ably well in managing their activities of daily living.
Similar results have been found in other studies with
chronic hand pathologies (Van Zelst et al. 2006). This
most likely reflects the chronic deterioration in hand
mobility, which enables adaptation. This may explain
why psychological scores were not affected by decreasing
Figure 2 Measure of function based on active range of movement. a. Graph representing the percentage active range of movement within
the cohort. b. Graph representing active range of movement against observer rated disfigurement.
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brought about a greater physical feeling of QOL.
The DASH was primarily used in the study to identify
whether its use had similar outcomes to the Inter-
national Registry on hand transplantation ADL question-
naire. The registry outcomes have never been applied to
the scleroderma population before, and in demonstrating
the correlation with SF-36 and the DASH, similarities
between the two populations have been demonstrated
which support the proposal that scleroderma is a useful
clinical model for hand CTA rejection. People with
higher scores on the DASH representing greater upper
limb disability, were found to demonstrate poorer QOL
outcomes with lower scores on both the physical and
mental components of the SF-36.
Scleroderma affects hand function and appearance,
which can lead to psychological distress. Psychological
problems are common amongst patients with chronic
illnesses such as scleroderma and may interact and ex-
acerbate functional disability and global disease. 40% of
individuals were borderline or classified as clinical cases
with anxiety. Furthermore, 32% of the cohort either had
borderline depression or were clinical cases. Despite the
majority of participants falling within the non-case cat-
egory, significant psychological distress was evident in a
small proportion of the cohort. In our cohort, pain was a
powerful predictor of depression and increasing feelings of
subjective limb disability, therefore we would suggest that
adequate pain control in these individuals requires careful
consideration (Benrud-Larson et al. 2002).
It is striking that individuals with scleroderma appear to
adapt their behaviour to cope with functional changes,
such that levels of disability remain remarkably low. Many
of the problems the condition poses are manageable, and
psychological resilience appears high overall with a minor-
ity of patients exhibiting psychological distress that require
clinical intervention. Nonetheless, ongoing and regular
screening for both pain and psychological distress would
be pertinent if chronic graft rejection were to take place,
allowing for considerable scope for positive early interven-
tion. Experience from solid organs transplantation shows
that high numbers of acute rejection results in a higher in-
cidence of chronic rejection. Similarly, in a rat hind limb
model, nerve regeneration and muscle activity were shown
not to be affected by a small number of acute rejections.
However, with increasing acute rejection, there is a signifi-
cant decline in function leading to atrophic and fibrotic
muscle. There was evidence of mononuclear cellular infil-
tration (Unadkat et al. 2013). It has been suggested that
the low rate of rejection observed in current hand allograft
is attributed to the short follow-up and early recognition
allowing reversal of acute rejection. Additional evaluation
of acute and chronic rejection in human hand and face
allograft is required to define its characteristics since no
definite signs of chronic rejection are present in any allo-
grafts to date, including the longest surviving allograft of
12 years (Whitaker et al. 2008).
It may be that the connection between scleroderma
and chronic rejection is not as strong as proposed within
the model. The pathophysiological processes do some-
what differ, in that scleroderma manifests with thicken-
ing of connective tissue within the deep dermis,
subcutaneous fat and muscular fascia, with thinning of
tissues in chronic rejection. An important difference be-
tween those from the scleroderma and hand transplant
cohort resides in the notion that hand amputees are
healthy and selected for transplantation on the basis they
do not have significant comorbidities impacting on in-
fection and malignancy. In addition, transplantation of
the hand is not life-saving and does not maintain long-
term survival.
Conclusion
We believe using scleroderma as a model for chronic re-
jection to be highly informative since it represents a
spectrum of chronic functional and psychological dis-
ability that may be encountered in chronic hand allograft
rejection, and therefore provides a useful addition to the
patient information and consent process. Cosmesis was
found not to be a significant stressor, and does not ap-
pear to impact significantly on QOL. However, func-
tional deterioration is considered paramount but looking
overall at individual QOL, most patients appear to be
coping well. After hand CTA we would hope for a dra-
matic increase in function, health and well-being. The
gradual deterioration in function from a chronic rejec-
tion process may have a psychological impact on trans-
plant recipients, but we have shown that individuals are
able to cope with this.
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